RecruitingNot ApplicableNCT06413550

The Efficacy of Hibiscus Sabdariffa in Xerostomia

The Efficacy of Hibiscus Sabdariffa L. Mouth Rinse in Head and Neck Cancer Patients With Xerostomia: A Randomized, Placebo-Controlled Clinical Trial


Sponsor

Ain Shams University

Enrollment

40 participants

Start Date

Apr 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this \[ type of study: Clinical trial\] is to test effectiveness of Hibiscus Sabdariffa L. mouth rinse using the subjective dry mouth score as a primary objective and to assess the effect of that mix on the salivary flow rate and objective dry mouth score as a secondary objective.


Eligibility

Min Age: 20 YearsMax Age: 70 Years

Inclusion Criteria5

  • Both genders, aged above 20 years.
  • All patients must have complaint of xerostomia.
  • Objective dry mouth score from ( 2-5).
  • Subjective dry mouth score from (1-4).
  • Patients must be able to make reliable decision or communications.

Exclusion Criteria5

  • \- Smoking, Alcohol.
  • Patient with history of any serious illness as malignancy.
  • Patients with any autoimmune disease.
  • Vulnerable groups such as pregnant females, prisoners, mentally and physically handicapped individuals.
  • Known hypersensitivity or severe adverse effects to the treatment drugs or to any ingredient of their preparation.

Interventions

BIOLOGICALHibiscus Sabdariffa

The fresh red Roselle plant was obtained; the red calyxes of Hibiscus Sabdariffa were separated from the plant and dried for a week at 25°C. The dried calyxes were ground to powder, kept in a sealed container, and stored in a refrigerator (4°C) until used. Aqueous Roselle calyx extract was prepared by adding 10 gm of the previously prepared powder to 100 ml of boiling water and then heated on a hot stirrer plate for 30 min. To remove the remnants, the mixture was filtered via Whatman No 1 filter paper (Whatman products, Springfield Paper Mill, Maidstone, UK). The water content of the filtered solution was evaporated using an air recirculation oven and then kept at 4°C in the dark until used to determine antibacterial effectiveness \[20\].


Locations(1)

Ahmed Maher Teaching Hosipital

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06413550


Related Trials